XML 45 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2015
Significant Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents and Investments
The following is a summary of cash, cash equivalents and investments at March 31, 2015 and December 31, 2014 (in thousands):

 
Amortized
Cost
  
Gross
Unrealized
Gains
  
Gross
Unrealized
Losses
  
Fair Value
 
As of March 31, 2015
        
Cash
 
$
11,521
  
$
-
  
$
-
  
$
11,521
 
Money market funds
  
5,289
   
-
   
-
   
5,289
 
Certificates of deposits
  
3,600
   
2
   
-
   
3,602
 
Commercial paper
  
2,996
   
-
   
-
   
2,996
 
Corporate notes and bonds
  
42,158
   
8
   
(34
)
  
42,132
 
U.S. government agency securities
  
7,497
   
4
   
-
   
7,501
 
  
$
73,061
  
$
14
  
$
(34
)
 
$
73,041
 
                 
Classified as:
                
                 
Cash and cash equivalents
 
$
16,810
  
$
-
  
$
-
  
$
16,810
 
Short-term investments
  
56,251
   
14
   
(34
)
  
56,231
 
  
$
73,061
  
$
14
  
$
(34
)
 
$
73,041
 
 
 
Amortized
Cost
  
Gross
Unrealized
Gains
  
Gross
Unrealized
Losses
  
Fair Value
 
As of December 31, 2014
        
Cash
 
$
9,572
  
$
  
$
  
$
9,572
 
Money market funds
  
9,859
   
   
   
9,859
 
Certificates of deposits
  
3,600
   
   
(5
)
  
3,595
 
Commercial paper
  
2,996
   
   
   
2,996
 
Corporate notes and bonds
  
45,819
   
   
(48
)
  
45,771
 
U.S. government agency securities
  
2,000
   
   
   
2,000
 
  
$
73,846
  
$
  
$
(53
)
 
$
73,793
 
                 
Classified as:
                
                 
Cash and cash equivalents
 
$
23,354
  
$
  
$
  
$
23,354
 
Short-term investments
  
50,492
   
   
(53
)
  
50,439
 
  
$
73,846
  
$
  
$
(53
)
 
$
73,793
 
Summary of Estimated Fair Value of Available-for-sale Securities Classified by Stated Maturity Date
The following table summarizes the estimated fair value of our available-for-sale securities classified by the stated maturity date of the security (in thousands):
 
  
March 31, 2015
  
December 31, 2014
 
Due within one year  
 
$
39,110
  
$
41,448
 
Due within two years  
  
17,121
   
8,990
 
  
$
56,231
  
$
50,438
 
Financial Assets (Cash Equivalents and Investments) Measured at Fair Value on Recurring Basis
In accordance with ASC 820, the following table represents our fair value hierarchy for our financial assets (cash equivalents and investments) measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 (in thousands):

As of March 31, 2015
 
Level 1
  
Level 2
  
Level 3
  
Total
 
Money market funds
 
$
5,289
  
$
  
$
  
$
5,289
 
Certificates of deposits
  
   
3,602
   
   
3,602
 
Commercial paper
  
   
2,996
   
   
2,996
 
Corporate notes and bonds
  
   
42,132
   
   
42,132
 
U.S. government agency securities
  
   
7,501
   
   
7,501
 
Total
 
$
5,289
  
$
56,231
  
$
  
$
61,520
 


As of December 31, 2014
 
Level 1
  
Level 2
  
Level 3
  
Total
 
Money market funds
 
$
9,859
  
$
  
$
  
$
9,859
 
Certificates of deposits
  
   
3,595
   
   
3,595
 
Commercial paper
  
   
2,996
   
   
2,996
 
Corporate notes and bonds
  
   
45,771
   
   
45,771
 
U.S. government agency securities
  
   
2,000
   
   
2,000
 
Total
 
$
9,859
  
$
54,362
  
$
  
$
64,221
 
Components of Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss, which relate entirely to accumulated foreign currency translation losses associated with our foreign subsidiaries and unrealized losses on investments, consisted of the following (in thousands):
 
  
Foreign
Currency
Translation
Losses
  
Unrealized
Losses on
Investments
  
Total
 
Balance as of December 31, 2014
  
(1,975
)
  
(53
)
  
(2,028
)
Current-period other comprehensive income (loss)
  
6
   
33
   
39
 
Balance as of March 31, 2015
 
$
(1,969
)
 
$
(20
)
 
$
(1,989
)
Fair Value of Stock-based Awards Valuation Assumptions
The fair value of our stock-based awards was estimated using the following weighted average assumptions for the three months ended March 31, 2015 and 2014:

  
Stock Option Plan
  
Employee Stock Purchase Plan
 
  
Three Months Ended March 31,
 
  
2015
  
2014(1)
  
2015
  
2014
 
Risk-free interest rate
  
1.3
%
    
0.1
%
  
0.1
%
Expected term (in years)
  
3.8
   
   
0.5
   
0.5
 
Volatility
  
56.6
%
  
   
37.2
%
  
53.7
%
Expected dividend
  
0
%
  
   
0
%
  
0
%
Weighted average grant-date fair value
 
$
0.80
   
  
$
0.55
  
$
1.34
 
 

(1)
The Company did not grant stock options to employees or directors during the three months ended March 31, 2014.
Stock-based Compensation Expense
We recorded the following stock-based compensation expense for the three months ended March 31, 2015 and 2014 (in thousands):

  
Three Months Ended
March 31,
 
  
2015
  
2014
 
Stock-based compensation expense related to grants of:
    
Stock options
 
$
252
  
$
336
 
Employee Stock Purchase Plan (“ESPP”)
  
20
   
29
 
Restricted stock units (“RSUs”)
  
439
   
257
 
  
$
711
  
$
622
 
Stock-based compensation expense recognized in:
        
Cost of service
 
$
62
  
$
87
 
Cost of software and other
  
4
   
3
 
Research and development
  
130
   
167
 
Sales and marketing
  
66
   
77
 
General and administrative
  
449
   
288
 
  
$
711
  
$
622
 
Computation of Basic and Diluted Earnings (Loss) per Share
The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share amounts):

  
Three months ended
March 31,
 
  
2015
  
2014
 
Net loss
 
$
(2,431
)
 
$
(482
)
Basic:
        
Weighted-average shares of common stock outstanding
  
54,237
   
53,313
 
Shares used in computing basic loss per share
  
54,237
   
53,313
 
Basic loss per share
 
$
(0.04
)
 
$
(0.01
)
Diluted:
        
Weighted-average shares of common stock outstanding
  
54,237
   
53,313
 
Add: Common equivalent shares outstanding
  
-
   
-
 
Shares used in computing diluted loss per share
  
54,237
   
53,313
 
Diluted loss per share
 
$
(0.04
)
 
$
(0.01
)
Potential Common Shares Outstanding Excluded from Computation of Diluted Loss per Share
The following potential common shares outstanding were excluded from the computation of diluted loss per share because including them would have been antidilutive (in thousands):

  
Three months ended
March 31,
 
  
2015
  
2014
 
Stock options
  
3,711
   
5,139
 
RSUs
  
1,370
   
1,152
 
Warrants
  
490
   
490
 
Total common share equivalents
  
5,571
   
6,781